| Date: |
2009-03-21 |
| Type: |
Association Events |
| Organizer: |
SABPA |
| Location: |
Institute of Americas, UCSD |
| Source: |
SABPA |
|
|
|
|
Biomarker, Pharmacogenomics and Personalized Medicine
Please click here for the photo report.
Date: March 21, 2009 (Saturday)
Location: Institute of Americas, UCSD
Pharmaceutical industry has been operating under the paradigm of “one drug fits all” for many decades. However, few drugs offer universal efficacy in all the patient population, and some even cause serious adverse effects in certain patient groups. These obstacles, in addition to the tougher FDA review standards and rapidly evaporating pipelines, have put unprecedented challenges on the drug industry, and inevitably push the industry to make increasing shift towards “the right drug to the right patient”, i.e. personalized medicine. The topic of SABPA Science & Technology Forum VII will focus on recent advances in the development of biomarkers, pharmacogenomics and personalized medicine. Experts from both the academia and industry will present overviews as well as specific examples of identifying novel genomic biomarkers, predicting drug efficacy and adverse effects, and using modern technologies such as high density microarray technology, genome-wide RNA expression profiling and DNA genotyping. These approaches are poised to dramatically shorten the drug development cycle, improve drug efficacy and safety, and ultimately deliver the right medicines tailored to the right patients.
Registraion: $20 for online registration, $10 for students and postdocs, $40 for onsite registration
Click here for registration.
Click here to make change of your registration.
Pre-registration online is closed. Registration onsite begins at 8:00 AM on March 21, 2009
Corporate Annual Pass Package:
$500 for 20 passes for all SABPA events for 12 months
Please contact: Feng Tian at tianfeng102@hotmail.com for this package.
Confirmed Speakers & Presentations
Click here for program
Nicholas J. Schork, Ph.D.
Director of Research, Scripps Genomic Medicine, Director of Biostatistics and Bioinformatics, The Scripps Translational Science Institute
Title: Genetic Variation, Association Studies, and Personalized Medicine
Click here for slides
Dominic Spinella, Ph.D.
Executive Director, Translational and Molecular Medicine, Pfizer Biotechnology and Bioinnovation Center (BBC)
Title: Personalized Medicine: Practical Considerations for Drug Development
Click here for slides
Wen Luo, Ph.D.
Research Investigator, New Leads Discovery, Ligand Pharmaceuticals
Title: Applying genomic biomarkers to predict drug response
Dominic Eisinger, Ph.D.
Director, Strategic Development, Rules Based Medicine
Title: Disease Related Protein Biomarker Profiles: Successful Strategies And Applications In Drug Development And Diagnostics
Click here for slides
Michael Nerenberg, M.D.
Sr VP for Medical Affairs, Business Development and CTO, Genoptix, Inc
Title: Practical aspects of adoption of Personalized Medicine in Oncology
Click here for slides
Bill Harten CEO/CTO, UNIConnect LC
A Genealogical Approach to Create Personalized Software for Personalized Medicine
Click here for slides |
|
